posted
MSGI Security Solutions Inc. (OTCBB: MSGI) today reported that the Company is launching its first product derived from NASA technology, a handheld test for Diabetes, which uses breath instead of blood.
Nanobeak Inc., an MSGI subsidiary, is a nanotechnology company focused on carbon based chemical sensing for gas and organic vapor detection. Nanobeak will take the prototype handheld sensor, which measures acetone levels with a simple breath, out of the laboratory and into the marketplace. The first step involves product testing which will be done in conjunction with a major hospital network in the United States, followed by licensing discussions with the top pharmaceutical companies.
According to the International Diabetes Federation, Diabetes currently affects 246 million people worldwide and is expected to affect 380 million by 2025. At least 50% of all people with Diabetes are unaware of their condition. In some countries this figure may reach 80%. Every 10 seconds a person dies from Diabetes-related causes. India has the largest number of people with Diabetes estimated at 40.9 million. According to the American Diabetes Association, there are 23.6 million children and adults in the United States with Diabetes.
Diabetes is a disease in which the body does not produce or properly use insulin. Insulin is a hormone that is needed to convert sugar, starches and other food into energy needed for daily life. The cause of Diabetes continues to be a mystery, although both genetics and environmental factors such as obesity and lack of exercise appear to play roles. Acetone is the organic compound with the formula OC(CH3)2. This colorless liquid is the simplest example of the ketones. Ketones are the byproduct of a process called Gluconeogenesis
Jeremy Barbera, Chairman and CEO of MSGI commented; “we are excited to announce the first breakthrough in technology that has reached the prototype stage resulting from our new relationship with NASA. With nearly 250 million people in the world affected by Diabetes, we see a clear opportunity to partner with a major pharmaceutical company in licensing our first product. This device will ultimately be marketed to consumers who will be able to determine their health risks with nothing more than a simple breath. If more than 50% of all people who have Diabetes are unaware of that fact, our product will provide a seamless test to save lives by providing early detection.
Nanobeak is the first of several majority owned subsidiaries, each of which will hold the rights to a specific technology. We will be announcing the other subsidiaries and their various breakthrough technologies over the course of the next several weeks.”
About MSGI Security Solutions
MSGI Security Solutions, Inc. is a leading international provider of proprietary solutions to commercial and government organizations. MSGI is developing a combination of innovative emerging businesses that leverage information and technology. The Company is headquartered in New York City where it serves the needs of counter-terrorism, public safety, and law enforcement. More information on MSGI is available on the company's website at www.msgisecurity.com. MSGI is a significant stakeholder in Current Technology Corporation.
The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Important factors, including general economic conditions, spending levels and other factors could cause actual results to differ materially from the Company's expectations.
Posts: 3230 | From: Los Angeles California | Registered: Jan 2006
| IP: Logged |
Spyware That Tests for Diabetes? Russell Phillips, PhD Oct 9, 2009
MSGI Security Solutions, which "serves the needs of counter-terrorism, public safety, law enforcement, and commercial security," has moved into a new area: diabetes detection. In fact, it has developed a handheld sensor that detects diabetes by measuring the level of acetone in the breath. The device, which employs carbon-based chemical sensors that detect organic vapors, is based upon nano sensors that NASA originally developed to make scientific measurements during space missions.
How does a sensor that detects acetone serve to diagnose diabetes? Because people with diabetes are resistant to insulin or don't produce it at all, their bodies are unable to move glucose from their bloodstream into their cells for energy. When the starved cells call for more glucose, the liver gets into action, converting fat into glucose in a process called gluconeogenesis ("gluco" = glucose; "neo" = new; and "genesis" = production). Gluconeogenesis produces substances called ketones. Ketones break down into three basic compounds, one of them being acetone, which then ends up in the breath.
According to the International Diabetes Federation (IDF), about half of the approximately 246 million people in the world who have diabetes don't know that they have the disease. Early detection would mean that early treatment could be made available. And early treatment, as we know, is absolutely necessary to prevent or delay the complications of diabetes. A simple breath test would go a long way toward simplifying early detection.
Please be aware, however, that this product is still in the prototype stage. MSGI has formed a subsidiary, Nanobeak, which is looking to test the handheld sensor and then license it to Big Pharma. It will then be up to Big Pharma to determine how to market the device to us, the consumers, or to our healthcare providers. (By the way, a nanobeak is a near-field optical head with a beaked metallic plate. Now you know.)
Posts: 3230 | From: Los Angeles California | Registered: Jan 2006
| IP: Logged |
posted
NASA, MSGI Partner for Solar Energy and Nanotechnology 5 minutes ago - Businesswire
As of 10:35 AM ET 10/27/09 The National Aeronautics and Space Administration ("NASA") and MSGI Security Solutions Inc. (OTCBB: MSGI) today announced under the terms of two Space Act Agreements, it will partner with MSGI, to advance solar cell technology and develop nano-chemical sensors. The solar cells will use semiconductor materials instead of silicon crystals and prepare them in a nanostructured form for greater efficiency. NASA and MSGI also will use nanotechnology and carbon-based chemical sensing to detect gas and organic vapors found in human breath.
NASA developed these two revolutionary nanotechnologies that now have promising alternative applications. Solar cells that powered space missions now may compete with conventional electricity as an energy source. An electronic sniffing sensor, used to monitor the air onboard the Space Shuttle, may be used for medical diagnoses and environmental monitoring.
"Silicon crystalline solar technology has limitations that this new nanostructured form and semiconductor technology will surpass," said Meyya Meyyappan, chief scientist for exploration technology and director of the Center for Nanotechnology at NASA's Ames Research Center, Moffett Field, Calif. "This has led NASA to investigate novel materials, substrates and production techniques with the goal of becoming more efficient while achieving lower production costs."
MSGI recently announced that its subsidiary companies will co-develop and commercialize these technologies. Andromeda Energy Inc., will focus on scalable renewable energy solutions that cost less per watt than conventional energy sources.
"We are committed to establishing a solar platform in Northern California, which will create new jobs and help stimulate the local economy, while reducing our dependence on traditional energy sources," said Jeremy Barbera, chairman and chief executive officer of MSGI Security Solutions, Inc.
Nanobeak Inc., is a nanotechnology company that develops carbon nanotube-based chemical sensing devices. It will soon launch its first prototype, derived from NASA technology, which is a handheld sensor that can detect diabetes. The device will measure specific signatures for diabetes by simply breathing into a personal handheld device. This will help eliminate expensive laboratory tests and inconvenient trips to the laboratory facility.
"This product will provide a simple, non-invasive test to save lives by providing early diabetes detection," said Barbera. "More than fifty percent of all people who have diabetes are unaware of that fact."
For more information about NASA's Innovative Partnership Program and NASA technology infusion activities, visit:
If you are a news media professional who would like to sign up for the 'local-reporters'" e-mail list for alerts about NASA feature stories on the web, please e-mail your request to Jonas Dino, Jonas.Dino@nasa.gov or give him a call at 650/604-5612. To unsubscribe, send an e-mail to local-reporters-request@lists.arc.nasa.gov with "unsubscribe" in the subject line.
About MSGI Security Solutions
MSGI Security Solutions, Inc. is a leading international provider of proprietary solutions to commercial and government organizations. MSGI is developing a combination of innovative emerging businesses that leverage information and technology. The Company is headquartered in New York City where it serves the needs of counter-terrorism, public safety, and law enforcement. More information on MSGI is available on the company's website at www.msgisecurity.com. MSGI is a significant stakeholder in Current Technology Corporation.
SOURCE: MSGI Security Solutions, Inc.
Ames Research Center, Moffett Field, Calif. Ruth Dasso Marlaire, 650-604-4709 ruth.d.marlaire@nasa.gov or MSGI Security Solutions Inc., San Francisco Jeremy Barbera, 415-971-4435 jbarbera@msgisecurity.com
Posts: 3230 | From: Los Angeles California | Registered: Jan 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
